上美股份2024年度报告

2024 Contents Corporate Information2Chairman’s Statement5Financial Summary24Management Discussion and Analysis25Biographical Details of Directors,Supervisors and Senior Management33Corporate Governance Report41Report of the Board of Directors71Report of the Supervisory Committee122Independent Auditor’s Report125Consolidated Statement of Profit or Loss136Consolidated Statement of Comprehensive Income137Consolidated Statement of Financial Position138Consolidated Statement of Changes in Equity140Consolidated Statement of Cash Flows142Notes to Financial Statements144 Corporate Information BOARD OF DIRECTORS Executive Directors Mr. Lyu Yixiong ()(Chairman of the Board and Chief Executive Officer)Ms. Luo Yan ()Mr. Feng Yifeng ()Ms. Song Yang () Non-executive Directors Ms. Li Hanqiong ()Mr. Sun Hao () Independent Non-executive Directors Mr. Leung Ho Sun Wilson ()Ms. Luo Yan ()Mr. Li Yang () (appointed on 30 May 2024)Mr. Liu Yi () (resigned on 30 May 2024)20245302024530 SUPERVISORS Mr. Li Tao ()(Chairman)Ms. Shi Tenghua ()Ms. Yang Min () (appointed on 21 August 2024)Ms. Cao Ying () (resigned on 21 August 2024)(2024821)2024821 JOINT COMPANY SECRETARIES Mr. Lian Ming ()Mr. Li Kin Wai ()(ACG, HKACG)ACG, HKACG AUDIT COMMITTEE Mr. Leung Ho Sun Wilson ()(Chairman)Ms. Luo Yan ()Mr. Li Yang () (appointed on 30 May 2024)Mr. Liu Yi () (resigned on 30 May 2024)20245302024530 REMUNERATION AND APPRAISALCOMMITTEE Ms. Luo Yan ()(Chairman)Mr. Lyu Yixiong ()Mr. Li Yang () (appointed on 30 May 2024)Mr. Liu Yi () (resigned on 30 May 2024)20245302024530 NOMINATION COMMITTEE 20245302024530Mr. Lyu Yixiong ()(Chairman)Ms. Luo Yan ()Mr. Li Yang () (appointed on 30 May 2024)Mr. Liu Yi () (resigned on 30 May 2024) AUTHORISED REPRESENTATIVES ACG, HKACGMr. Feng Yifeng ()Mr. Li Kin Wai ()(ACG, HKACG) AUDITORS Ernst & Young(Certified Public Accountants andRegistered Public Interest Entity Auditor)27/F, One Taikoo Place979 King’s RoadQuarry BayHong Kong LEGAL ADVISORS as to Hong Kong lawsEric Chow & Co. in Associationwith Commerce & Finance Law Offices3401, Alexandra House18 Chater RoadCentralHong Kong 183401 as to PRC laws 1515110Commerce & Finance Law Offices10/F, Tower 1Jing An Kerry Centre1515 West Nanjing RoadShanghaiPRC REGISTERED OFFICE Room 701No. 515 Yinxiang RoadNanxiang TownJiading District, ShanghaiPRC 515701 HEAD OFFICE AND PRINCIPAL PLACEOF BUSINESS IN THE PRC 3300B2525 Floor, Building BNo. 3300 Zhongshan North RoadPutuo District, ShanghaiPRC PRINCIPAL PLACE OF BUSINESS INHONG KONG 33191918Room 1918, 19/FLee Garden One33 Hysan AvenueCauseway BayHong Kong PRINCIPAL BANKERS 7557Shanghai Pudong Development Bank Co., Ltd.(Fengxian Sub-Branch)No. 7557 Nanfeng RoadFengxian DistrictShanghai, PRC 1589China Merchants Bank Co., Ltd.(Shanghai Century Avenue Sub-Branch)No. 1589 Century AvenuePudong New DistrictShanghai, PRC HHONG KONG H SHARE REGISTRARAND TRANSFER OFFICE 1617Tricor Investor Services Limited17/F, Far East Finance Centre16 Harcourt RoadHong Kong STOCK CODE 21452145 COMPANY’S WEBSITE www.chicmaxgroup.comwww.chicmaxgroup.com Iampleasedtopresentourannualreportfortheyearended31December 2024. FINANCIAL HIGHLIGHTS OurrevenueincreasedtoRMB6,792.5millioninthefullyearof2024 from RMB4,190.7 million in the full year of 2023. Our grossprofit increased to RMB5,109.4 million in the full year of 2024 fromRMB3,019.5 million in the full year of 2023. Our profit for the full yearof 2024 was RMB803.3 million whereas our profit for the full year of2023 was RMB461.7 million. Final Dividend of RMB0.75 per share was proposed by the Board forthe year ended 31 December 2024. The final dividend for the yearended 31 December 2023 of RMB0.75 per share was approved bythe shareholders at general meeting held on 30 May 2024. The interimdividends for the six months ended 30 June 2024 of RMB0.75 pershare was approved by the shareholders at general meeting held on30 September 2024. BUSINESS REVIEW AND OUTLOOK BUSINESS REVIEW We are a multi-brand cosmetics company, focusing on research anddevelopment, manufacturing and sales of skincare products, maternityandchildcareproducts,washingandpersonalcareproductsandmakeupproducts.Wefocusontheimplementationofmulti-brandstrategy and have remained dedicated to it since our establishment.Withanoperationalhistoryofmorethan20years,todayweareone of the front runners in China’s cosmetics industry, possessingcomprehensivemulti-branddevelopment,operationalcapabilityandexpertise, and we have successfully built a variety of popular cosmeticbrands. Our decisive strategy originally to embark on and persist witha multi-brand strategy gives us an advantage to timely grasp marketopportunities and sets us apart from our peers. KANS 20Launchedin2003,KANS ,beingpositionedasa“scientificanti-aging”skincarebrand,focusesonaddressingtheevolvinganti-aging needs of Asian females of various age groups, with a broadtarget customer base, and is positioned to be a go-to brand in theanti-aging skin